ANRO- Alto Neuroscience, Inc.
Alto Neuroscience, Inc. (ANRO) has 8 insiders with recent SEC Form 4 filings, including 9 buys and 0 sells. ANRO is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 45.0K | $1.22M | - | |
| CEO | 34.6K | $936.1K | - | |
| Other | 22.5K | $607.9K | - | |
| COO | 8.0K | $216.3K | - | |
| Dir | 7.2K | $194.4K | - |
Activity
Buys and sells only
Transactions
6 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 10, 2024 | Savitz Adam | Chief Medical Officer | Buy | 15,000 | $12.72 | $190,832.95 | +15.4% | -10.6% | -79.5% | |
| Mar 28, 2024 | Smith Nicholas Conrad | Chief Financial Officer | Buy | 6,150 | $16.36 | $100,628.00 | +14.3% | -35.1% | -85.2% | |
| Feb 6, 2024 | Alpha Wave Global, LP | 10% Owner | Buy | 600,000 | $16.00 | $9,600,000.00 | +19.3% | -26.3% | -78.3% | |
| Feb 6, 2024 | Smith Nicholas Conrad | Chief Financial Officer | Buy | 1,563 | $16.00 | $25,008.00 | New | -26.3% | -78.3% | |
| Feb 6, 2024 | Savitz Adam | Chief Medical Officer | Buy | 17,000 | $16.00 | $272,000.00 | +216.5% | -26.3% | -78.3% | |
| Feb 6, 2024 | Etkin Amit | President And CEO | Buy | 3,125 | $16.00 | $50,000.00 | +0.3% | -26.3% | -78.3% |